Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1025 of 1631 entries
View as:

Clinical Study to Evaluate the Maximum Tolerated Dose of BAY87-2243 in Patients With Advanced Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01297530 Org: User:
Start: 04/30/11 End: 07/31/12 Due: 07/31/13

Russian Kogenate Pediatric Study

Phase: N/A Priority: Normal
NCT ID: NCT00632814 Org: User:
Start: 06/30/07 End: 09/30/09 Due: 09/30/10

A Study to Learn How Safe the Study Treatment BAY2701250 is, How it Affects the Body and How it Moves Into, Through and Out of the Body in Healthy Male Participants When a Single Amount is Given as an Injection Into the Vein (Intravenous Infusion) or Under the Skin (Subcutaneous Injection)

Phase: N/A Priority: Normal
NCT ID: NCT06048120 Org: User:
Start: 09/15/23 End: 05/20/25 Due: 05/20/26

Exploratory Study for Allergy Relief Onset

Phase: N/A Priority: Normal
NCT ID: NCT02722083 Org: User:
Start: 05/07/16 End: 07/13/16 Due: 07/13/17

Study of Betaferon Adherence in Patients With Multiple Sclerosis Treated With Interferon Beta-1b

Phase: N/A Priority: Normal
NCT ID: NCT03408093 Org: User:
Start: 02/03/09 End: 03/30/10 Due: 03/30/11

Safety, Tolerability and Pharmacokinetics of Single Dose Intravenous Moxifloxacin in Pediatric Patients

Phase: N/A Priority: Normal
NCT ID: NCT01049022 Org: User:
Start: 05/31/10 End: 08/31/13 Due: 08/31/14

Study to Assess on a Molecular Level the Influence of a 5 % Dexpanthenol Ointment in Subjects With Superficial Injuries

Phase: N/A Priority: Normal
NCT ID: NCT00859196 Org: User:
Start: 02/28/09 End: 03/31/09 Due: 03/31/10

Drug-drug Interaction (DDI) Study to Assess ODM-201 as a Victim of CYP3A4 Inhibition or Induction

Phase: N/A Priority: Normal
NCT ID: NCT03048110 Org: User:
Start: 02/15/17 End: 07/19/17 Due: 07/19/18

Phase 1b/2 Study of Rogaratinib (BAY1163877) in Combination With Atezolizumab in Urothelial Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03473756 Org: User:
Start: 05/15/18 End: 07/10/24 Due: 07/10/25

A Study to Learn How Finerenone (BAY94-8862) Moves Into, Through and Out of the Body, How it Affects the Body, and How Safe it is in Adult Participants With Different Degrees of Reduced Liver Function and in Healthy Participants With Similar Age, Weight and Gender Distribution

Phase: N/A Priority: Normal
NCT ID: NCT04881994 Org: User:
Start: 03/25/14 End: 12/08/14 Due: 12/08/15

CAPRIVI: Community Acquired Pneumonia: Treatment With Avelox® in Hospitalized Patients

Phase: N/A Priority: Normal
NCT ID: NCT00987792 Org: User:
Start: 09/30/09 End: 10/31/12 Due: 10/31/13

Study to Learn How the Drug Aflibercept Works in in Japanese Patients With Increased Eye Pressure That is Caused by New Blood Vessels Growing in the Eye (Neovascular Glaucoma or NVG). Safety of the Drug and Patients' Tolerability of the Drug Injection is Also Studied

Phase: N/A Priority: Normal
NCT ID: NCT03639675 Org: User:
Start: 10/03/18 End: 03/14/19 Due: 03/14/20

Comparative Efficacy of Ovule vs Tablet

Phase: N/A Priority: Normal
NCT ID: NCT00755053 Org: User:
Start: 09/30/08 End: 05/31/09 Due: 05/31/10

BEYOND Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT00893217 Org: User:
Start: 11/30/02 End: 06/30/03 Due: 06/30/04

A Long-term Extension Study of Riociguat in Patients With Symptomatic Pulmonary Arterial Hypertension.

Phase: N/A Priority: Normal
NCT ID: NCT02759419 Org: User:
Start: 06/16/16 End: 12/28/25 Due: 12/28/26

Multiple Dose Study in Heart Failure of BAY 1067197

Phase: N/A Priority: Normal
NCT ID: NCT02040233 Org: User:
Start: 01/28/14 End: 04/02/15 Due: 04/02/16

Efficacy and Safety Oral Contraceptive Study

Phase: N/A Priority: Normal
NCT ID: NCT00185484 Org: User:
Start: 03/31/04 End: 01/31/06 Due: 01/31/07

Aflibercept for Retinopathy of Prematurity - Intravitreal Injection Versus Laser Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04004208 Org: User:
Start: 09/25/19 End: 02/12/21 Due: 02/12/22

Evaluate Safety and Efficacy of an OC Preparation vs Placebo for 6 Treatment Cycles in Women With Moderate Acne.

Phase: N/A Priority: Normal
NCT ID: NCT00651469 Org: User:
Start: 01/31/03 End: 07/31/04 Due: 07/31/05

Special Drug Use Investigation of Glucobay OD

Phase: N/A Priority: Normal
NCT ID: NCT01685502 Org: User:
Start: 11/30/10 End: 08/31/14 Due: 08/31/15

Sorafenib as Neoadjuvant Therapy Before Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01982097 Org: User:
Start: 01/10/14 End: 12/07/17 Due: 12/07/18

BAY88-8223, Alpharadin, Breast Cancer Patients With Bone Dominant Disease

Phase: N/A Priority: Normal
NCT ID: NCT01070485 Org: User:
Start: 01/31/10 End: 01/31/12 Due: 01/31/13

Safety and Efficacy of BAY 50-4798 in Patients With HIV Infection

Phase: N/A Priority: Normal
NCT ID: NCT00059462 Org: User:
Start: 12/31/02 End: 03/31/05 Due: 03/31/06

Pharmacokinetic Study Comparing Aspirin and Effervescent Aspirin

Phase: N/A Priority: Normal
NCT ID: NCT01081353 Org: User:
Start: 02/28/10 End: 03/31/10 Due: 03/31/11

Regorafenib in Indian Patients With Metastatic Colorectal Cancer (mCRC).

Phase: N/A Priority: Normal
NCT ID: NCT03564938 Org: User:
Start: 07/30/18 End: 12/01/23 Due: 12/01/24